In 2010, Laney and coworkers evaluated serum calcium, creatinine, albumin, and 25-hydroxy vitamin D (25-OH-D) in patients with thyroid nodule (42), thyroid cancer in remission (45), and active thyroid cancer (24) and found that serum 25-OH-D was not different between groups. This evidence concerns the gene ALB and thyroid cancer.